Microsoft PowerPoint - (Juvic) Korean-Swiss Life Science Symposium

Similar documents
04-다시_고속철도61~80p

00내지1번2번

歯1.PDF

<32382DC3BBB0A2C0E5BED6C0DA2E687770>


DBPIA-NURIMEDIA


¹Ìµå¹Ì3Â÷Àμâ

±èÇö¿í Ãâ·Â

11¹Ú´ö±Ô

#Ȳ¿ë¼®


<BFA9BAD02DB0A1BBF3B1A4B0ED28C0CCBCF6B9FC2920B3BBC1F62E706466>

歯3이화진

레이아웃 1

,.,..,....,, Abstract The importance of integrated design which tries to i

AT_GraduateProgram.key

시안

Á¶´öÈñ_0304_final.hwp

, ( ) 1) *.. I. (batch). (production planning). (downstream stage) (stockout).... (endangered). (utilization). *

세종대 요람

大学4年生の正社員内定要因に関する実証分析

06_ÀÌÀçÈÆ¿Ü0926

16-기06 환경하중237~246p

1. 서론 1-1 연구 배경과 목적 1-2 연구 방법과 범위 2. 클라우드 게임 서비스 2-1 클라우드 게임 서비스의 정의 2-2 클라우드 게임 서비스의 특징 2-3 클라우드 게임 서비스의 시장 현황 2-4 클라우드 게임 서비스 사례 연구 2-5 클라우드 게임 서비스에

1. KT 올레스퀘어 미디어파사드 콘텐츠 개발.hwp

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: * The


<BCF6BDC D31385FB0EDBCD3B5B5B7CEC8DEB0D4C5B8BFEEB5B5C0D4B1B8BBF3BFACB1B85FB1C7BFB5C0CE2E687770>

11¹ÚÇý·É

50-5대지05장후은.indd

03.Agile.key

학습영역의 Taxonomy에 기초한 CD-ROM Title의 효과분석

30이지은.hwp

한국성인에서초기황반변성질환과 연관된위험요인연구

ÀÌÁÖÈñ.hwp

歯_ _ 2001년도 회원사명단.doc

6 영상기술연구 실감하지 못했을지도 모른다. 하지만 그 이외의 지역에서 3D 영화를 관람하기란 그리 쉬운 일이 아니다. 영화 <아바타> 이후, 티켓 파워에 민감한 국내 대형 극장 체인들이 2D 상영관을 3D 상영관으로 점차적으로 교체하는 추세이긴 하지만, 아직까지는 관

대한한의학원전학회지24권6호-전체최종.hwp

12È«±â¼±¿Ü339~370

07_À±¿ø±æ3ÀüºÎ¼öÁ¤

Analyses the Contents of Points per a Game and the Difference among Weight Categories after the Revision of Greco-Roman Style Wrestling Rules Han-bong

-

Company_Introduction_2014_623

2003 Digital for Next Generation

03-ÀÌÁ¦Çö

①국문지리학회지-주성재-OK

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: NCS : * A Study on

민속지_이건욱T 최종

1.장인석-ITIL 소개.ppt

°í¼®ÁÖ Ãâ·Â

Vol.259 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M

Development of culture technic for practical cultivation under structure in Gastrodia elate Blume

09김정식.PDF

_Prain Global 회사소개서_pt용

<B1E2C8B9BEC828BFCFBCBAC1F7C0FC29322E687770>

¹ýÁ¶ 12¿ù ¼öÁ¤.PDF

PJTROHMPCJPS.hwp


강의지침서 작성 양식

LG Electronics Inc. I 2002 I Based on its insight into the needs of the digital age and on its innovative technology, LG Electronics is aiming t

DBPIA-NURIMEDIA

001지식백서_4도

½Éº´È¿ Ãâ·Â

<313920C0CCB1E2BFF82E687770>

원고스타일 정의

<BFACBCBCC0C7BBE7C7D E687770>

ÀÌÀç¿ë Ãâ·Â

GEAR KOREA

( )

02이용배(239~253)ok


Output file

27송현진,최보아,이재익.hwp

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: * A Research Trend

12Á¶±ÔÈŁ

< C6AFC1FD28B1C7C7F5C1DF292E687770>

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

국내 디지털콘텐츠산업의 Global화 전략

공연영상

인문사회과학기술융합학회

Vol.258 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M

아태연구(송석원) hwp

<31362DB1E8C7FDBFF82DC0FABFB9BBEA20B5B6B8B3BFB5C8ADC0C720B1B8C0FC20B8B6C4C9C6C32E687770>

슬라이드 1

2 I.서 론 학생들을 대상으로 강력사고가 해마다 발생하고 있다.범행 장소도 학교 안팎을 가리지 않는다.이제는 학교 안까지 침입하여 스스럼없이 범행을 하고 있는 현실 이 되었다.2008년 12월 11일 학교에 등교하고 있는 학생(여,8세)을 교회 안 화장 실로 납치하여

2013<C724><B9AC><ACBD><C601><C2E4><CC9C><C0AC><B840><C9D1>(<C6F9><C6A9>).pdf

05_±è½Ã¿Ł¿Ü_1130

歯kjmh2004v13n1.PDF

11. 일반 10 김린 지니 3(cwr).hwp

20(53?)_???_O2O(Online to Offline)??? ???? ??.hwp

0929 °úÇбâ¼úÁ¤Ã¥-¿©¸§

<B3EDB9AEC1FD5F3235C1FD2E687770>

서론 34 2

BSC Discussion 1

Journal of Educational Innovation Research 2016, Vol. 26, No. 1, pp.1-19 DOI: *,..,,,.,.,,,,.,,,,, ( )

Å©·¹Àγ»Áö20p

<B9AEC8ADB0E6C1A6BFACB1B820C1A63137B1C720C1A633C8A C2F720BCF6C1A4BABB292E687770>

Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ

<B9AEC8ADC4DCC5D9C3F7BFACB1B82D35C8A32833B1B3292E687770>

Transcription:

Application of Microneedles in Cosmetic and Medicine Hyungil Jung, Professor, Department of Biotechnology, Yonsei University Founder and CEO, Juvic Inc. hijung@yonsei.ac.kr

Microneedle is referred to micro dimensioned needles It is a novel delivery method to deliver drugs across the skin in a minimally invasive manner Microneedle patch Skin Application Delivery 2

Microneedle can be utilized in various fields of beauty, medical, cell therapy and beauty clinics. Beauty Anti wrinkle Whitening Alopecia treatment Beauty Clinic Acne Alopecia treatment Botox Medical Insulin patch PTH EPO Microlancet Cell Therapy Influenza Vaccine Arthritis treatment 3

According to analysis of Frost & Sullivan, Microneedle was selected as top 10 technologies of Healthcare & Wellness in 2016 Microneedle market Billion dollar "Drug delivery technology market has continued to grow rapidly due to impressive sales growth and trends." (BBC Research) "Micro-needles are likely to replace existing syringes, which will increase demand for micro-needles in the future." (Frost & Suliivan) Frost & Sullivan, 2014 4

Currently, microneedle fabrication technologies are focused on cosmetics field. Main elements of dissolving microneedle delivery systems You want to deliver 1. Your valuable drugs 2. Maintains its activity 3. With high efficacy Drug Loading Fabrication Application

Activity of EGF Activity of Ascorbic acid Centrifugal Lithography 6

Drug Drug Polymer solution MN Centrifugal Lithography MN Delivery Solvent Drug Activity Preparation Storage Delivery efficacy Fabrication Process time

Formulation Technology Innovative polymer system (Any drugs) Fabrication Technology Centrifugal lithography (Various conditions) Delivery Technology Micro injector (Perfect delivery) Can load all type of drugs by amphipathic polymer system Can control easily the conditions to conserve the activity of drug Can deliver DMN in high efficacy by shooting DMN into skin All technologies are combined Into innovative products through JUVIC JUVIC provides Total solution for Healthcare with Microneedle

Juvic is a technology based start-up. Representative Hyungil Jung, Junbae Kim Founded on 2015.10. Publications and patents Various patents on microneedle fabrication and delivery methods (5 registered, 40 applied) Advanced Materials (2010, 2012), Scientific Reports (2015) etc. about 30 publications Location Main owners Yonsei University, Engineering Park Hyungil Jung Yonsei University, etc. Achievements Yonsei University Industry-University Cooperation Excellence Award (2009) Yonsei University Award of Excellent Achievement The 1st Yonsei University startup Award (2016) Awarded from Ministry of the Future Creation Science Prize for Excellent Technology Commercialization (2015) Technology transfer 7 transfers, 2 successful production 9

We are carrying out various national R&D projects in both cosmetics and medical fields. Projects Project Title Department Our role Assignment amount Duration New Industry Creation Project Future Creation Science Division Beauty patch development $ 1.5 Million 2015.07~2017.06 Social problem solving technology development Future Creation Science Division Korea Research Foundation Insulin needle development $ 0.2 Million 2015.11~2017.11 Private investment-led technology start-up support Small and Medium Business Administration Micro type patch development $ 0.5 Million 2016.12~2018.12 10

Ready for beauty patch for production 11

High efficiency and stability of biopharmaceuticals Dissolving microneedles Hollow microneedles Pharmaceutical Patch (Insulin and vaccine) Tuberculosis Patch Painless anesthesia patch Alopecia patech Insulin microneedles Smart tdiagnosis patch 12

OEM/ODM Business Our primary business target is to develop and commercialize dissolving microneedle beauty products and medical products in long term. Early business model: OEM/ODM for cosmetics Order from cosmetic partner Beauty patch production A Long term business: Medical Collaboration Medical patch production

No.1 Bio & Pharma Technology Pharmaceutics World best drug delivery & microneedle Technology Vaccination Cosmetics Lead in the Next Generation Medical & Cosmetics Field

Thank You 15

Various beauty / medical patches and smart touch patches for diagnosis based on our novel fabrication technique Cosmetics patch Controlled release Bio Patch 마이크로구조체 Micro structure Medical patch Implantable Micro-capsule Micro-injector Alopecia treatment Painless needles Diagnostic systems Microfluidics chip 16

We are planning to enter biopharmaceutical industry in near future. Polymer biopharmaceutical technology polymer Drug No activity loss during fabrication Fabrication High efficiency and stability of biopharmaceuticals Potential of delivering lipophilic drugs (arthritis etc. Maximization effect of anti-metabolism Drug encapsulating microneedle 17

Based on the target site, Microneedles are fabricated in solid, hollow and dissolving types. Microneedle types SOLID HOLLOW DISSOLVING Drugs are coated over the outer layer of microneedle Drugs are delivered by creating channels into skin Delivers liquid drugs via hollow channels Dissolves inside the skin upon penetration and releases the encapsulated drug 18

Currently, microneedle fabrication technologies are focused on cosmetics field. Our manufacturing technology can be extended to medical field. From cosmetics to medical field Competitors Comparison Our technology Local competitors International competitors Technology Centrifugal lithography DAB Micromolding Micromolding Company Juvic A Endo derma, Wellage, other companies Georgia tech Cos medi Fabrication time Less than 10 min Less than 10 min Over 3 hours Manufacturing process 2 steps Dispensing > Fabrication 3 steps Dispensing > drawing > air blow More than 3 steps Mold fabrication > Substanse insertion > centrifuge > drying > separation Target drug Unstable protein drugs can be utilized Mainly applicable to small molecule chemicals and is difficult to apply biopharmaceuticals due to fabrication temperature and air drying. Microneedle fabrication pattern Technology development time Flexible Micro mold should be re-designed 2014 10 2010 4 2006 1 2002 1 19

We have developed biodegradable micro-fabrication technology using Centrifugal Lithography and also developed an applicator technology that can deliver various drugs such as water-soluble / lipid-free with high efficiency. Main elements of dissolving microneedle delivery systems Drug Loading Fabrication Application Capable of loading all sort of substances 2 related patents applied Capability of fabrication in short time and at low temperature 2 related patents applied High delivery efficiency 2 related patents applied Scalability of drugs No activity loss High efficiency 20

Contents 21

JUVIC Through a variety of applicator technologies, we can effectively deliver encapsulated substances to the target site. Sticky Film Microneedle Microneedle Painless anesthesia patch Pharmaceutical Patch (Insulin) Tuberculosis Patch 22

Juvic has developed an innovative polymer system that can mix lipid soluble drugs (more than 50% of drugs) in microneedles. Traditional microneedles were not capable of encapsulating lipid soluble drugs Innovative polymer system Capable of encapsulating lipid soluble drugs 23

Dissolving microneedles fabricated via centrifugal lithography showed lower drug activity loss compared with other manufacturing processes (such as DAB) Comparison of centrifugal lithography and DAB fabrication methods Activity of EGF Activity of Ascorbic acid 24

Microneedle applicator device Microlancer shooting device Alopecia treatment 25

Juvic is a start up company founded in October 2015 Company Representative Juvic, Inc. Founded on 2015.10. Address Hyungil Jung, Junbae Kim Seoul, Yonsei University, Engineering Building Investment 204 Million won (2017.02) Main owners Hyungil Jung Yonsei University, etc. Government Project 2016.12 Selected for Small and Medium Business Administration project 2016.05 Transferred 45 patents related to microneedles from Yonsei University 2016.05. Awarded the 1st Prize of startup at Yonsei University 2015.11. Selected for social problem solving technology development project 2015.10. Founded Juvic 2015.07. Selected for new industrial project 26

Based on our innovative biodegradable micro-fabrication technology, we have developed a beauty patch using lab scale pilot equipment. Our technology Centrifugal Lithography Lab-Scale Pilot Cosmetic patch fabrication 27

II. 기술개발준비현황 ( 창업팀 ) JUVIC 논문게재및연구결과를 45 건의특허로권리화, 기술권리를확보함. < 마이크로니들관련핵심특허보유 > < 특허분석수행 > 마이크로니들저온제작관련핵심특허를자체보유하고있으며, 보유특허를통한미세돌기스킨케어시스템을이용한셀프필러제품구현가능함. IP컨설팅수행을통해기존지식재산권과침해여부분석완료했으며, 연세대학교산학협력단을통한기술유출방지대책마련완료함. 28

II. 기술개발준비현황 ( 창업팀 ) JUVIC 주빅공동대표이사정형일 1993 연세대학교졸업 1995 연세대학교식품공학석사 2002 미코넬대학교생명공학박사 2004~ 현재연세대학교생명공학과교수 2015~ 현재연세대학교최초교원창업기업주식회사주빅설립 미용및의약품경피전달체기술관련원천기술및특허다수보유성공적기술이전 ( 총 7건 ) 및사업화 ( 총 2건 ) 이력보유 미래융합의료기기개발 ( 한국보건산업진흥원 ) GMP 인증및사업화 서울전략산업지원사업 ( 서울산업통상진흥원 ) 화장품패치사업화및수출 미래창조과학부장관우수기술사업화성과표창장수상 사업화컨설팅수행 29

II. 기술개발준비현황 ( 창업팀 ) JUVIC 주빅공동대표이사김준배 1996 연세대학교졸업 2000 미퍼듀대학교경영학과석사 2004 KTB 네트워크투자심사역 2010 셀루메드 CFO 2012 코렌텍 CFO 2016~ 현재연세대학교최초교원창업기업주식회사주빅공동대표 국책과제수행벤처기업경영, 내부통제시스템구축및운영경험보유 국책과제수행기관 ( 벤처기업 ) 경영총괄 (3 개사 ) 재무 / 회계 / 자금등내부통제시스템구축및운영 30

II. 기술개발준비현황 ( 창업팀 ) JUVIC 논문게재및연구결과를 45 건의특허로권리화, 기술권리를확보함. < 마이크로니들관련핵심특허보유 > < 특허분석수행 > 마이크로니들저온제작관련핵심특허를자체보유하고있으며, 보유특허를통한미세돌기스킨케어시스템을이용한셀프필러제품구현가능함. IP컨설팅수행을통해기존지식재산권과침해여부분석완료했으며, 연세대학교산학협력단을통한기술유출방지대책마련완료함. 31

II. 기술개발준비현황 ( 창업팀 ) JUVIC 주빅공동대표이사정형일 1993 연세대학교졸업 1995 연세대학교식품공학석사 2002 미코넬대학교생명공학박사 2004~ 현재연세대학교생명공학과교수 2015~ 현재연세대학교최초교원창업기업주식회사주빅설립 미용및의약품경피전달체기술관련원천기술및특허다수보유성공적기술이전 ( 총 7건 ) 및사업화 ( 총 2건 ) 이력보유 미래융합의료기기개발 ( 한국보건산업진흥원 ) GMP 인증및사업화 서울전략산업지원사업 ( 서울산업통상진흥원 ) 화장품패치사업화및수출 미래창조과학부장관우수기술사업화성과표창장수상 사업화컨설팅수행 32

II. 기술개발준비현황 ( 창업팀 ) JUVIC 주빅공동대표이사김준배 1996 연세대학교졸업 2000 미퍼듀대학교경영학과석사 2004 KTB 네트워크투자심사역 2010 셀루메드 CFO 2012 코렌텍 CFO 2016~ 현재연세대학교최초교원창업기업주식회사주빅공동대표 국책과제수행벤처기업경영, 내부통제시스템구축및운영경험보유 국책과제수행기관 ( 벤처기업 ) 경영총괄 (3 개사 ) 재무 / 회계 / 자금등내부통제시스템구축및운영 33